Internet Pharmaceutical Sites Under Scrutiny

Article

Clinton Administration Proposes Legislation to Regulate Pharmaceutical Websites

WASHINGTON, DC--In response to the increased Internet use to buy medical products, the Clinton Administration has proposed new legislation to regulate the sale of pharmaceuticals over the Internet. The initiative would give the FDA more power to regulate, investigate, and prosecute sites that do not comply with federal and state pharmaceutical sales laws. Online pharmacies would have to demonstrate their compliance to the FDA prior to commencing operations or be subject to sanctions.

The FDA currently has the authority to take legal action; however, the new initiative would give them administrative subpoena authority when investigating potential fraudulent sites. Targeted are sites that sell unapproved or counterfeit drugs, or false "miracle" drugs. Additionally, the proposal creates a $500,000 fine per violation for online selling of prescription drugs to individuals without valid prescriptions.

The Fiscal Year 2001 budget has earmarked $10 million to enhance the FDA's computer technology and fund a public education program regarding the safe purchase of pharmaceutical products on the Internet.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.